Navigation Links
ACC and CRF announce partnership on ACC's Innovation in Intervention: i2 Summit
Date:5/28/2008

(MAY 28, 2008 -- WASHINGTON, DC) The American College of Cardiology (ACC) and the Cardiovascular Research Foundation (CRF) announced today a multi-year partnership to jointly sponsor the ACC i2 interventional cardiology meeting in Orlando, Fla., March 2831, 2009, during ACC.09, the ACCs 58th Annual Scientific Session and the worlds premier cardiovascular meeting. This will be the beginning of a five-year partnership committed to collectively developing the interventional component of the ACC Annual Scientific Session.

The ACCs Innovation in Intervention: i2 Summit in partnership with the Cardiovascular Research Foundation in Orlando will deliver in-depth and cutting-edge science provided in a forum for both general cardiologists and interventional specialists, educating and guiding physicians, as well as cardiac care team members, to the next level of knowledge and practice. The meeting will emphasize the translation of evidence-based science and clinical trial data into daily interventional practice.

We are honored to partner with the ACC to organize and enhance the preeminent interventional cardiology meeting of the spring, said Gregg W. Stone, M.D., Chairman of the Cardiovascular Research Foundation and professor of medicine at Columbia University Medical Center/New York-Presbyterian Hospital. The annual scientific session of the American College of Cardiology represents a unique opportunity to introduce the latest advances in interventional medicine to the greater cardiology community. It is our hope that CRFs expertise in cutting edge medical education will help appropriately translate evidence-based science into clinical practice.

The i2 Summit will offer unsurpassed evidence-based content, presented by leaders in interventional cardiology, and this collaboration brings together the strengths and expertise of both the ACC and CRF to deliver an unparalleled program that appeals to all cardiovascular professionals, said ACC President Douglas Weaver, M.D. The ACC is committed to providing more value to attendees at our meeting by having a wide venue of educational opportunities for physicians including state-of-the-art updates, late breaking clinical trials and education required for credentialing and recertification.

The program committee will assemble a broad-based group of domestic and international interventional cardiologists and other heart disease specialists to provide a forum for interventional cardiology experts to discuss new developments within the field as well as a focused venue to train, educate and guide their colleagues in intervention and cardiac care. The program will feature late-breaking clinical trials, case-based education, and analysis of advances in treating diseases of the coronary, vascular, and peripheral vessels as well as pediatric and structural heart disease.

In the coming weeks, additional details about the meeting will be announced.


'/>"/>

Contact: Judy Romero
jromero@crf.org
212-851-9311
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. DRAXIS Announces Completion of Sale to Jubilant
2. WellPoint Announces Realignment of Operations, Technology and Government Services Unit
3. Hill-Rom Announces Third Quarter 2008 Dividend
4. VirtualHealth Technologies, Inc. Announces Management Appointment
5. CYNACON / OCuSOFT(R) Announces OCuSOFT(R) Lid Scrub(TM) PLUS Now Available in CVS Pharmacies
6. Innolife Pharma Inc. Announces The Launching Of A New And Improved Website
7. Watson Announces Oxybutynin Topical Gel NDA Accepted for Filing by FDA for the Treatment of Overactive Bladder
8. ABC, CBS, NBC Announce Historic Collaboration to Stand Up To Cancer
9. ABC, CBS, NBC announce historic collaboration to stand up to cancer
10. Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership
11. Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Express Scripts Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... ... According to an article published February 4th on mySA, robotically ... hernia repairs throughout the United States. Commenting on this article, Beverly Hills hernia repair ... has not only been expected, but it seems to be a natural result of ...
(Date:2/12/2016)... ... ... Enforcement Trends: , Back to the Future , Feb. 25, 2016 — 11:00 a.m. – ... who don’t learn from history are doomed to repeat it.” , An analysis of CDRH’s ... But that takes time. , Take a close look at the warning letters the ...
(Date:2/12/2016)... ... February 12, 2016 , ... T.E.N., ... have closed for the ISE Southeast Awards 2016. Finalists and winners of the ... ISE® Southeast Executive Forum and Awards Gala on March 15, 2016 at the ...
(Date:2/12/2016)... ... 12, 2016 , ... AssureVest Insurance Group, a locally owned insurance firm with ... will raise funds earmarked to purchase computers and software for Mrs. Harrison’s 2nd and ... is in a low-income area and has more than 60 2nd and 3rd graders ...
(Date:2/12/2016)... ... February 12, 2016 , ... Donor Network West, the organ procurement organization that ... partnership with San Ramon Regional Medical Center. Under the collaboration, the first of its ... to accommodate a more certain time frame for donor families for the recovery of ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 12, 2016  SI-BONE, Inc., a medical device company that pioneered ... minimally invasive surgical (MIS) device indicated for fusion for certain disorders ... (NGS), the Medicare Administrative Contractor (MAC) covering the states of ... Maine , Massachusetts , Minnesota ... York , Rhode Island , ...
(Date:2/12/2016)... SAN DIEGO and SEOUL, ... -- Silicon Biosys­tems Menarini and Macrogen, Inc. today ... clinical assays and innovative procedures for precision medicine ... to combine Silicon Biosystems, DEPArray™ digital-sorting technology with ... development of tests certified under the Clinical Laboratory ...
(Date:2/12/2016)... , Feb. 12, 2016  Apellis Pharmaceuticals, ... a $47.1 million Series D preferred stock ... Management, Hillhouse Capital Group and venBio Global ... Investments, AJU IB Investment, and Epidarex Capital. The ... to further advance clinical trials in the ...
Breaking Medicine Technology: